Automated classification of a new grading system for diabetic maculopathy based on optical coherence tomography by deep learninng

Author:

Cai Liwei1,Wen Chi2,Jiang Jingwen3,Zheng Hongmei1,Su Yu1,Chen Changzheng1

Affiliation:

1. Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan

2. School of Computer Science, Wuhan University, Wuhan

3. State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou

Abstract

Abstract Purpose: To develop a Vision Transformer model to detect different stages of diabetic maculopathy (DM) based on optical coherence tomography (OCT) images. Methods: A total of 3319 OCT images were extracted from the department of ophthalmology renmin hospital of wuhan university and randomly split the dataset into training and validation sets in a 7:3 ratio. All macular cross-sectional scan OCT images were collected retrospectively from the eyes of DM patients from 2016 to 2022. One of the OCT stages of DM, including early diabetic macular edema (DME), advanced DME, severe DME, and atrophic maculopathy, was labeled on the collected images respectively. A deep learning (DL) model based on Vision Transformer was trained to detect four OCT grading of DM. Results: The model proposed in our paper can provide a detection results effectively. We achieved a mean accuracy of 82.00%, a mean F1 score of 83.11%, a mean AUC of 0.96. The AUC for the detection of four OCT grading (i.e., early DME, advanced DME, severe DME, and atrophic maculopathy) was 0.96, 0.95, 0.87 and 0.98, respectively, with a precision of 88.46%, 80.31%, 89.42% and 87.74%, respectively, a sensitivity of 87.03%, 88.18%, 63.39% and 89.42%, respectively, a specificity of 93.02%, 90.72%, 98.40%, 96.66%, respectively and a F1 score of 87.74%, 84.06%, 88.18% and 88.57%, respectively. Conclusion: Our DL model based on Vision Transformer demonstrated a relatively high accuracy in the detection of OCT grading of DM,, which can help with patients in early screening to obtain a good visual prognosis. These results emphasized the potential of artificial intelligence in assisting clinicians in developing therapeutic strategies with DM in the future .

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3